Takeda Pharmaceutical Company Limited Dividend History (TAK)
Takeda Pharmaceutical Company Limited will distribute a dividend of $0.326079 per share on December 12, 2024 (7 days)
🤑 Takeda Pharmaceutical Company Limited has distributed a total of 11 dividends from 2019 to 2024
📉 During this 5 period their dividend has seen a -29.95% decrease in the payout amount
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a global, research-driven biopharmaceutical company founded in 1781 and headquartered in Tokyo, Japan. With a strong commitment to improving patient health worldwide, Takeda specializes in several therapeutic areas including oncology, gastroenterology, neuroscience, and rare diseases. As of 2023, Christophe Weber serves as the company's President and CEO, having led the company through significant growth and innovation. Takeda is recognized for its robust R&D capabilities and dedication to advancing science to address unmet medical needs. The company has a substantial global footprint, with operations in over 80 countries and regions, and reported revenue of approximately $26 billion in recent years. Takeda's vision centers on leveraging its expertise to deliver innovative medicines that make a difference in people's lives.
The global activated carbon fiber (ACF) market is expected to reach a value of USD 762.85 Million by 2031, driven by increasing demand for efficient filtration and purification solutions across various industries. Synthetic materials are dominating the market due to their enhanced adsorption capacity and durability, while the wastewater treatment segment is leading the market due to the growing need for effective pollution control.
GlobeNewswire Inc. · Published on Tue Dec 03 2024HUTCHMED announces the launch of its cancer drug FRUZAQLA (fruquintinib) in Japan for the treatment of metastatic colorectal cancer, following approval by the Japanese Ministry of Health, Labour and Welfare. The launch marks a milestone in HUTCHMED's partnership with Takeda, which has the exclusive worldwide license to develop and commercialize fruquintinib outside of mainland China, Hong Kong and Macau.
GlobeNewswire Inc. · Published on Fri Nov 22 2024Previous Payouts (11)
The most recent dividend Takeda Pharmaceutical Company Limited paid out was on July 8, 2024 (150 days ago) for $0.292214 per share
Pay Date | Amount |
---|---|
July 8, 2024 | $0.292214 |
December 11, 2023 | $0.319068 |
July 10, 2023 | $0.30996 |
December 12, 2022 | $0.329553 |
July 11, 2022 | $0.330062 |
December 13, 2021 | $0.396898 |
July 12, 2021 | $0.406627 |
December 11, 2020 | $0.430533 |
July 6, 2020 | $0.419053 |
December 12, 2019 | $0.411118 |
July 10, 2019 | $0.417168 |
Dividend data last updated Thu, 05 Dec 2024 05:28:22 GMT UTC